Literature DB >> 29674272

COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells.

Xiaolin Pu1, Jun Wang2, Wei Li3, Weifei Fan2, Lin Wang2, Yuan Mao2, Shu Yang2, Suyao Liu2, Juqing Xu2, Zhigang Lv4, Lin Xu5, Yongqian Shu6.   

Abstract

Lung adenocarcinoma is the most common subtype of non-small cell lung cancer and responsible for more than 500,000 deaths per year worldwide. In this study, we aimed to explore the effects of COPB2 in the progression of lung adenocarcinoma and its underlying mechanism. The mRNA and protein levels of COPB2 in tumor tissues and cell lines were determined by qRT-PCR and western blotting analysis. siRNAs and over-expressed vector targeting COPB2 were used to down-regulate and up-regulate COPB2 expression in lung adenocarcinoma cell lines H1975. Cell apoptosis rate, proliferation and tumorigenesis of H1975 cells were determined by flow cytometry analysis, MTT assay and in vivo xenotransplantation assay, respectively. Western blotting and immunofluorescence assays were performed to evaluate the effects of COPB on the expression and subcellular location of YAP. Results showed COPB2 was significantly up-regulated in lung adenocarcinoma tissues and cell lines, which showed a close correlation with advanced clinical symptoms, such as tumor differentiation, TNM stage and the occurrence of lymph node metastasis and distance metastasis. Besides, the overall survival time of patients with high expression of COPB2 was shorter than that of patients with low COPB2 expression. After knockdown of COPB2, cell apoptosis rate was increased, whereas cell proliferation was decreased. Compared with that in the normal lung cell line H1688 cells, YAP1 expression was obviously increased in H1975, and over-expression of COPB2 translocated YAP1 from cytoplasm to nuclear, whereas knockdown of COPB2 showed the opposite effect. Overexpression of COPB2 enhanced cell proliferation, tumorigenesis and inhibited cell apoptosis. However, these effects were abolished when down-regulated YAP1 expression on the base of COPB2 over-expression. In conclusion, the increased expression of COPB2 was significantly correlated with the progression of lung adenocarcinoma. Up-regulation of COPB2 inhibited cell apoptosis and promoted cell growth and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Apoptosis; COPB2; Lung adenocarcinoma; Proliferation; Tumorigenesis; YAP1

Mesh:

Substances:

Year:  2018        PMID: 29674272     DOI: 10.1016/j.biopha.2018.04.006

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  13 in total

1.  LncRNA HOTAIRM1 Inhibits the Proliferation and Invasion of Lung Adenocarcinoma Cells via the miR-498/WWOX Axis.

Authors:  Tian-Jun Chen; Fei Gao; Tian Yang; Hong Li; Yang Li; Hui Ren; Ming-Wei Chen
Journal:  Cancer Manag Res       Date:  2020-06-09       Impact factor: 3.989

2.  Prognostic significance of nuclear Yes-associated protein 1 in patients with nonsmall cell lung cancer: A systematic review and meta-analysis.

Authors:  Lingling Zhu; Guangzhi Ma; Jiewei Liu; Yunfu Deng; Qiang Wu; Wenjie Chen; Qinghua Zhou
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

3.  COPB2 is up-regulated in breast cancer and plays a vital role in the metastasis via N-cadherin and Vimentin.

Authors:  Adheesh Bhandari; Chen Zheng; Namita Sindan; Namrata Sindan; Ruida Quan; Erjie Xia; Yubaraj Thapa; Dependra Tamang; Ouchen Wang; Xiaohe Ye; Duping Huang
Journal:  J Cell Mol Med       Date:  2019-05-22       Impact factor: 5.310

4.  LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.

Authors:  Wenlong He; Yeying Zhang; Shulan Xia
Journal:  Thorac Cancer       Date:  2020-01-10       Impact factor: 3.500

5.  SAG expression associates with COPB2-related signaling and a poorer prognosis in breast cancer.

Authors:  Aiyu Liu; Shizhen Zhang; Weihan Li; Biao Xu; Rui Lei; Shengmei Zhu
Journal:  Aging (Albany NY)       Date:  2020-01-11       Impact factor: 5.682

6.  Upregulation of the Coatomer Protein Complex Subunit beta 2 (COPB2) Gene Targets microRNA-335-3p in NCI-H1975 Lung Adenocarcinoma Cells to Promote Cell Proliferation and Migration.

Authors:  Xiaolin Pu; Hua Jiang; Wei Li; Lin Xu; Lin Wang; Yongqian Shu
Journal:  Med Sci Monit       Date:  2020-01-31

7.  COPB2: A Novel Prognostic Biomarker That Affects Progression of HCC.

Authors:  Jiayao Zhang; Xiaoyu Wang; Guangbing Li; Jingyi He; Ziwen Lu; Yang Yang; Yong Jiang; Liyong Jiang; Feiyu Li; Jun Liu
Journal:  Biomed Res Int       Date:  2021-03-20       Impact factor: 3.411

8.  An Integrative Pan-Cancer Analysis of the Oncogenic Role of COPB2 in Human Tumors.

Authors:  Biao Wu; Yumeng Wu; Xianlin Guo; Yanping Yue; Yuanyuan Li; Xiao He; Yuanbin Chen; Wenjing Zhao; Jibin Liu; Xuming Wu; Aiguo Shen; Suqing Zhang
Journal:  Biomed Res Int       Date:  2021-10-12       Impact factor: 3.411

9.  High expression of COPB2 predicts adverse outcomes: A potential therapeutic target for glioma.

Authors:  Yan Zhou; Xuan Wang; Xing Huang; Xu-Dong Li; Kai Cheng; Hao Yu; Yu-Jie Zhou; Peng Lv; Xiao-Bing Jiang
Journal:  CNS Neurosci Ther       Date:  2019-11-11       Impact factor: 5.243

10.  COPB2 promotes metastasis and inhibits apoptosis of lung adenocarcinoma cells through functioning as a target of miR-216a-3p.

Authors:  Mingxue Wang; Renjie Yu; Xuefeng Ling; Wa Cao; Yunyun Liu; Lei Fang; Jianlin Tong
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.